BioCardia Inc Sustainability Reports
BioCardia, Inc. is a clinical-stage regenerative medicine company focused on developing cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its pipeline includes cell therapy programs like CardiAMP and specialized intramyocardial delivery systems.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493003EDBXRQRW22O75
FIGI: BBG001S72MS0
3 reports from 2017 to 2024
